--- title: Martin Marietta Materials (MLM) — intrinsic value and fair price canonical: https://sweetvaluelab.com/stocks/mlm ticker: MLM as_of: 2026-10-17 sector: Basic Materials industry: Construction Materials --- # Martin Marietta Materials (MLM) Martin Marietta Materials (MLM) closed at $500.84 on Oct 16, 2026, overvalued by 54% vs its model value of $325.50 (from a five-year discounted cash flow). ## Key figures | Figure | Value | | --- | ---: | | Last close | $500.84 (Oct 16, 2026) | | Model value (from a five-year discounted cash flow) | $325.50 | | Price vs model | overvalued by 54% vs model | | Range of that model | $194.54 – $704.71 | | Market value | $30.1B | | P/E (fiscal 2025) | 26.7 | | Net margin (fiscal 2025) | 17.4% | | Free cash flow (fiscal 2025) | $978.0M | | Dividend yield (trailing twelve months) | 0.66% | | Beta | 1.08 | | Cost of capital (WACC) | 8.66% | | Business classification | Cyclical (Revenue declining (~-5% recent), Moderate margins (18% net margin), Highly cyclical earnings) | ## On the stock lists | List | Place | Figure | Page | | --- | ---: | ---: | --- | | Near 52-week lows | #50 | +6.3% | https://sweetvaluelab.com/lists/near-52-week-lows | ## Dividends | Figure | Value | | --- | ---: | | Trailing dividend yield | 0.66% | | Dividends per share, last 12 months | $3.33 | | Dividends / free cash flow (fiscal 2025) | 20.1% | | Raised | 10 years in a row | | Growth over 5 years | 7.5% a year | | Latest payment | $0.84, ex-date Sep 1, 2026, paid Sep 30, 2026 | | Year of payments | Dividends per share | | --- | ---: | | To Aug 31, 2021 | $2.32 | | To Aug 31, 2022 | $2.49 | | To Aug 31, 2023 | $2.72 | | To Sep 3, 2024 | $3.01 | | To Sep 2, 2025 | $3.20 | | Trailing twelve months (to Sep 1, 2026) | $3.33 | ## Valuation models Each model's value per share and the role the engine gave it for this business. The headline above is one model's value; every other model is listed with its own, and each has a page of its own under the valuation. Computed Oct 17, 2026. | Model | Role | Value per share | Low | High | | --- | --- | ---: | ---: | ---: | | DCF · Perpetuity growth · 5y | primary | $325.50 | $194.54 | $704.71 | | DCF · Perpetuity growth · 10y | cross check | $498.82 | $307.64 | $1,050.52 | | DCF · EBITDA exit · 5y | cross check | $392.86 | $201.69 | $619.28 | | DCF · EBITDA exit · 10y | cross check | $562.60 | $307.34 | $909.49 | | P/E · peers | cross check | $255.79 | $159.72 | $270.87 | | P/E · own history | cross check | $539.01 | $467.46 | $585.39 | | PEG | sanity check | $163.83 | $163.83 | $163.83 | | EV/EBITDA · peers | cross check | $250.80 | $209.43 | $294.13 | | EV/Revenue · peers | cross check | $130.55 | $84.72 | $149.07 | | Earnings power value | cross check | $63.20 | $41.07 | $94.61 | | Dividend discount | cross check | $65.71 | $46.67 | $101.25 | ## Insider activity (SEC Form 4) No open-market insider buys or sales filed in the past 90 days. | Date | Insider | Relationship | Transaction | Shares | Value | | --- | --- | --- | --- | ---: | ---: | | Sep 1, 2026 | Petro Michael J | SVP and CFO | Grant / award | 9,331 | $0 | | Aug 31, 2026 | WAJSGRAS DAVID C | Director | Grant / award | 78 | $40,458.6 | | Aug 31, 2026 | Pike Thomas | Director | Grant / award | 66 | $34,234.2 | | Aug 31, 2026 | LYONS MARTIN J | Director | Grant / award | 68 | $35,271.6 | | Aug 21, 2026 | Niemann Philipp | Director | Grant / award | 337 | $0 | ## Recent SEC filings | Filed | Form | What | Filing | | --- | --- | --- | --- | | Sep 16, 2026 | 8-K | 1.01 Entry into a Material Agreement; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/916076/000095015726001024/form8-k.htm | | Aug 24, 2026 | 8-K | 1.01 Entry into a Material Agreement; 2.01 Completion of Acquisition/Disposition; 3.02 Unregistered Sale of Equity; 5.02 Departure/Election of Directors or Officers; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/916076/000095015726000946/form8-k.htm | | Aug 18, 2026 | 8-K | 1.01 Entry into a Material Agreement; 1.02 Termination of a Material Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/916076/000095015726000922/form8-k.htm | | Aug 14, 2026 | 8-K | 1.01 Entry into a Material Agreement; 2.03 Creation of a Direct Financial Obligation; 8.01 Other Events; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/916076/000119312526352270/d103352d8k.htm | | Aug 12, 2026 | 8-K | 1.01 Entry into a Material Agreement; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits | https://www.sec.gov/Archives/edgar/data/916076/000119312526346914/d149482d8k.htm | ## Superinvestors holding it (latest 13F) | Manager | Quarter | Shares | Value | | --- | --- | ---: | ---: | | Chris Hohn | 2026-06-30 | 1,315,109 | $758.4M | | Thomas Russo | 2026-06-30 | 705,367 | $406.8M | | Wallace Weitz | 2026-06-30 | 47,370 | $27.3M | 3 tracked managers in all. ## About Martin Marietta Materials, Inc. functions as a company specializing in natural resource-derived building materials. This enterprise delivers a wide range of aggregates and other heavy construction components to the building industry, serving both domestic and international markets. Its product portfolio includes foundational raw materials like crushed stone, sand, and gravel, in addition to manufactured items such as ready-mix concrete, asphalt, and comprehensive paving solutions. These offerings are essential for infrastructure projects, commercial and residential developments, and various other sectors including railroads, agriculture, utilities, and environmental applications. Beyond its core construction offerings, Martin Marietta also produces magnesia-based chemicals, which are utilized in industrial, agricultural, and environmental contexts. The company further supplies dolomitic… --- Source: https://sweetvaluelab.com/stocks/mlm (SweetValueLab, free, no account). Prices and statements from Financial Modeling Prep; filings from SEC EDGAR. Research and educational data, not investment advice; nothing here is a recommendation to buy, sell or hold any security.